These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26349566)

  • 21. Pharmacodynamic Effects, Pharmacokinetics, and Metabolism of the Synthetic Cannabinoid AM-2201 in Male Rats.
    Carlier J; Wohlfarth A; Salmeron BD; Scheidweiler KB; Huestis MA; Baumann MH
    J Pharmacol Exp Ther; 2018 Dec; 367(3):543-550. PubMed ID: 30266766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LC-MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine--an Australian perspective.
    de Jager AD; Warner JV; Henman M; Ferguson W; Hall A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 897():22-31. PubMed ID: 22521213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
    Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A sensitive GC-EIMS method for simultaneous detection and quantification of JWH-018 and JWH-073 carboxylic acid and hydroxy metabolites in urine.
    Paul BD; Bosy T
    J Anal Toxicol; 2015 Apr; 39(3):172-82. PubMed ID: 25691387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry.
    Carlier J; Scheidweiler KB; Wohlfarth A; Salmeron BD; Baumann MH; Huestis MA
    J Chromatogr A; 2016 Jun; 1451():97-106. PubMed ID: 27208987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples.
    Mogler L; Wilde M; Huppertz LM; Weinfurtner G; Franz F; Auwärter V
    Drug Test Anal; 2018 May; 10(5):886-891. PubMed ID: 29314750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue.
    Sobolevsky T; Prasolov I; Rodchenkov G
    Drug Test Anal; 2015 Feb; 7(2):131-42. PubMed ID: 25428705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitive screening of synthetic cannabinoids using liquid chromatography quadrupole time-of-flight mass spectrometry after solid phase extraction.
    Kleis JN; Hess C; Germerott T; Roehrich J
    Drug Test Anal; 2021 Aug; 13(8):1535-1551. PubMed ID: 33884774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of urinary metabolites of XLR-11 by liquid chromatography-quadrupole time-of-flight mass spectrometry.
    Jang M; Kim IS; Park YN; Kim J; Han I; Baeck S; Yang W; Yoo HH
    Anal Bioanal Chem; 2016 Jan; 408(2):503-16. PubMed ID: 26514671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic patterns of JWH-210, RCS-4, and THC in pig urine elucidated using LC-HR-MS/MS: Do they reflect patterns in humans?
    Schaefer N; Helfer AG; Kettner M; Laschke MW; Schlote J; Ewald AH; Meyer MR; Menger MD; Maurer HH; Schmidt PH
    Drug Test Anal; 2017 Apr; 9(4):613-625. PubMed ID: 27328899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.
    Ammann J; McLaren JM; Gerostamoulos D; Beyer J
    J Anal Toxicol; 2012 Jul; 36(6):372-80. PubMed ID: 22593567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic properties of the synthetic cannabinoid JWH-018 in oral fluid after inhalation.
    Toennes SW; Geraths A; Pogoda W; Paulke A; Wunder C; Theunissen EL; Ramaekers JG
    Drug Test Anal; 2018 Apr; 10(4):644-650. PubMed ID: 28967189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.
    Borg D; Tverdovsky A; Stripp R
    J Anal Toxicol; 2017 Jan; 41(1):6-16. PubMed ID: 27681343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS/MS.
    Yanes EG; Lovett DP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():42-50. PubMed ID: 23153643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicological findings of synthetic cannabinoids in recreational users.
    Kronstrand R; Roman M; Andersson M; Eklund A
    J Anal Toxicol; 2013 Oct; 37(8):534-41. PubMed ID: 23970540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures.
    Grigoryev A; Melnik A; Savchuk S; Simonov A; Rozhanets V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2519-26. PubMed ID: 21803006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of (synthetic) cannabinoids in pigs and their relevance for clinical and forensic toxicology.
    Schaefer N; Wojtyniak JG; Kettner M; Schlote J; Laschke MW; Ewald AH; Lehr T; Menger MD; Maurer HH; Schmidt PH
    Toxicol Lett; 2016 Jun; 253():7-16. PubMed ID: 27113702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New challenges in toxicology of new psychoactive substances exemplified by fatal cases after UR-144 and UR-144 with pentedrone administration determined by LC-ESI-MS-MS in blood samples.
    Rojek S; Korczyńska-Albert M; Kulikowska J; Kłys M
    Arch Med Sadowej Kryminol; 2017; 67(2):104-120. PubMed ID: 29363897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic properties of the synthetic cannabinoid JWH-018 and of its metabolites in serum after inhalation.
    Toennes SW; Geraths A; Pogoda W; Paulke A; Wunder C; Theunissen EL; Ramaekers JG
    J Pharm Biomed Anal; 2017 Jun; 140():215-222. PubMed ID: 28365515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.